Clinical Trial Update: Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the feasibility and safety of the NeuroFlo device in ischemic stroke patients receiving tissue plasminogen activator, and the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NeuroFlo

Snippet

Sponsor: CoAxia | Conditions: Ischemic Stroke | Phase 1 | Status: COMPLETED